3451 - 3460 of 9038 Results
Title
Year
-
OPENTitle: Sex differences for phenotype in pathologically defined dementia with Lewy bodiesJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 92Issue #: 7Start Page: 745End Page: 750Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2020-325668Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8530264Citation Count: 51
-
OPENTitle: Copy Number Variation in Parkinson's Disease: An Update from Sub‐Saharan AfricaJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2442End Page: 2444Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28710Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8530875Citation Count: 5
- Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression2021OPENTitle: Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2444End Page: 2446Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28715Best OA location URL: https://doi.org/10.1002/mds.28715Citation Count: 66
-
OPENTitle: An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocolJournal Name: Pilot and Feasibility StudiesPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 24End Page: 24Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40814-022-00988-3Best OA location URL: https://pilotfeasibilitystudies.biomedcentral.com/track/pdf/10.1186/s40814-022-00988-3Citation Count: 15
-
OPENTitle: Mapping brain structural differences and neuroreceptor correlates in Parkinson’s disease visual hallucinationsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 519End Page: 519Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-28087-0Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/5fb2b0df-3d7e-4038-b91f-80c6299dc098Citation Count: 36
-
OPENTitle: Genetic risk, adherence to a healthy lifestyle, and cognitive decline in African Americans and European AmericansJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 4Start Page: 572End Page: 580Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12435Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8789942Citation Count: 34
-
OPENTitle: Lamina-specific immunohistochemical signatures in the olfactory bulb of healthy, Alzheimer’s and Parkinson’s disease patientsJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 88End Page: 88Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-022-03032-5Best OA location URL: https://www.nature.com/articles/s42003-022-03032-5.pdfCitation Count: 33
-
OPENTitle: PhosPiR: an automated phosphoproteomic pipeline in RJournal Name: Briefings in BioinformaticsPublisher: Oxford University Press (OUP)Vol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/bib/bbab510Best OA location URL: https://academic.oup.com/bib/article-pdf/23/1/bbab510/43308900/bbab510.pdfCitation Count: 9
-
OPENTitle: Functional MAOB Gene Intron 13 Polymorphism Predicts Dyskinesia in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2022Issue #: 1Start Page: 5597503End Page: 5597503Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/5597503Best OA location URL: https://downloads.hindawi.com/journals/pd/2022/5597503.pdfCitation Count: 5
- Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis2021OPENTitle: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia GravisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 4Start Page: e376End Page: e389Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121Best OA location URL: https://n.neurology.org/content/neurology/98/4/e376.full.pdfCitation Count: 133